Sabine Straus

Dr. Sabine Straus has been with the Medicines Evaluation Board (MEB) in the Netherlands since 1997, where she started as an assessor Pharmacovigilance.

Prior to working at the MEB she held different positions in the pharmaceutical industry, the last one as medical director.

She holds a PhD from the Erasmus Medical Center in Rotterdam ( title “Drugs, Qtc prolongation and sudden cardiac death”).

Since the start of the Pharmacovigilance Risk Assessment Committee (PRAC) in 2012 she has been the Dutch PRAC member and staff member at the MEB.

In that period she co-chaired the Signal Management Review Team (SMaRT),

and has been active in several drafting groups for guidance and guidelines.

Since 2018 she chairs the PRAC.

In addition to her work at the MEB she holds a position as associate professor at the Erasmus Medical Center, department of Medical Informatics in Rotterdam.